跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
autologous CD34+ cell therapy
首页
药物
autologous CD34+ cell therapy
autologous CD34+ cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy
US 6361997 B1
申请人: HUSS RALF
优先权: 1998
US
Ex-vivo expansion method under clinical grade conditions of haematopoietic stem cells isolated from bone marow to treat ischaemic diseases such as acute myocardial infartcion
EP 2039759 A1
申请人: FAGIOLI FRANCA
优先权: 2007
EP
COMPOSITIONS, CELLS, KITS AND METHODS FOR AUTOLOGOUS STEM CELL THERAPY
US 2013302293 A1
申请人: WEBSTER KEITH A
优先权: 2011
US
LIPID NANOPARTICLE LOADED WITH ANTITUMORAL AGENT AND FUNCTIONNALIZED TO TARGET IMMOSUPPRESSIVE CELLS
WO 2025202213 A9
申请人: INST NAT SANTE RECH MED
优先权: 2024
WO
药物
反馈